In the Volgograd region, they have revisited the idea of creating a chemical-pharmaceutical cluster. Representatives of the Scientific Center for Innovative Medicines with the experimental-industrial production facility of the Volgograd State Medical University are conducting relevant negotiations with potential partners.
In the Volgograd region, discussions about creating a chemical-pharmaceutical cluster have resurfaced. Such plans have been in development since 2011, as previously reported by Farmatsiya Vedomosti (Pharmaceutical Bulletin). Now, representatives of the Scientific Center for Innovative Medicinal Products with an experimental-industrial production facility at the Volgograd State Medical University (NCIMP VolgGMU) are conducting negotiations with Russian and foreign pharmaceutical manufacturers, according to Denis Babkov, Director of NCIMP and Vice-Rector for Research at VolgGMU, who spoke with Farmatsiya Vedomosti .
"We are negotiating with new potential partners: there are pharmaceutical companies that feel constrained within the Kaluga Pharmaceutical Cluster, and there are Indian manufacturers of pharmaceutical substances seeking to localize production in Russia. Meanwhile, our region has facilities capable of developing regulations for active pharmaceutical ingredients—such as VolgGTU—and others for their production—like the Volgograd branch of the Institute of Catalysis of the Siberian Branch of the Russian Academy of Sciences and JSC 'Volzhsky Orgsintez,'” Babkov noted.
The cluster is envisioned as a union of legal entities, with NCIMP playing a role in drug creation, while pharmaceutical companies would handle their production and distribution.
Source: Pharmaceutical BULLETIN
